News Desk: The United States and South Africa have temporarily suspended the use of Johnson & Johnson vaccines to prevent coronavirus. The European Union (EU) has also suspended the supply of vaccines. The decision was made considering the risk of blood clots as a result of the application of this vaccine.
Although blood clots formed after receiving the vaccine in the United States, it has not yet occurred in the EU and South Africa. They are heeding the warnings of the US health authorities. The World Health Organization (WHO) is monitoring the whole situation. The British media reported on the BBC.
Concerns have been raised in the United States among those who have received a single dose of Johnson & Johnson vaccine. Although health workers say there is no reason to panic. The vaccine has been discontinued in all states since April 13. The supply of Pfizer and Modern is being increased in the vaccination centers. Those who have received the Johnson & Johnson vaccine have been asked to report any side effects to their respective physicians immediately.
The country’s Federal Health Service announced on April 13 that it would suspend the use of Johnson & Johnson vaccines in the wake of rare blood clots in the bodies of six vaccinators. All six are women between the ages of 18 and 48. They develop problems within one to three weeks of receiving the vaccine. One of the women died and another was in critical condition at a Nebraska hospital.
The health department authorities think, “Johnson & Johnson Ticker’s blood clotting problem is so rare that even knowing it shouldn’t be a problem for people to get vaccinated.
As a precautionary measure, Johnson & Johnson’s vaccination has been suspended, but most people in the United States will be able to be vaccinated on time. The Federal Department of Health says the vaccination program will not be disrupted as a result. A statement from the White House said, “There is an adequate supply of Pfizer and modern vaccines and the target of 30 lakhs vaccines per day will remain unchanged.”
According to the Centers for Disease Control and Prevention (CDC), about 70 lakh people in the United States have been vaccinated against Johnson & Johnson so far, and another 90 lakh doses have been sent to various states in the country.
Director of the Biological Evaluation and Research Center of the Department of Food and Drugs. Dr. Peter Marks and Chief Deputy Director of the Government Center for Disease Control and Prevention. “As a precautionary measure, we are stopping the use of this vaccine,” Annie Schuchat said in a joint statement. At the moment, this negative reaction seems to be very rare. ”
Public health experts fear Johnson & Johnson’s vaccine could cause blood clots. “The health authorities’ offer to stop vaccinations will further discourage those who are reluctant to get vaccinated.”
The Johnson & Johnson vaccine has also been suspended in the EU. The U.S. agency began vaccinating countries in the EU this week.
Just 24 hours before the vaccines were sent to EU countries, Johnson & Johnson said they had suspended European vaccinations. However, the EU has not yet made a decision. Their experts are looking to the next step in the United States.
Johnson & Johnson provided the first vaccine in South Africa. No blood clots have been reported in the country since the vaccine was administered. About three million health workers in the country have been vaccinated against Johnson & Johnson since mid-February.
Like Johnson & Johnson, the Oxford-AstraZeneca in the UK is in trouble in the European market. The same technology is used for both ticks. It uses mutated and harmless viruses. The use of the Oxford and AstraZeneca vaccines has resulted in very low blood clots in some countries. Since then, many countries have stopped using the vaccine. In some countries the vaccine is only given to older people.